Study on Clinical Observation and Pharmaceutical Care of Patients with Chronic Heart Failure Based on the Platform of Clinical Pharmacists and Medical Alliance
Objective To observe the clinical and pharmaceutical care effect of patients with chronic heart failure based on the platform of clinical pharmacists and medical alliance.Methods A total of 420 patients with chronic heart failure who were treated in our hospital from September 2020 to October 2022 were selected as the research objects.They were divided into control group(n=210)and observation group(n=210)by random number table method.The control group received routine observation and treatment,and the observation group was given clinical pharmacist supervision based on the medical alliance platform on the basis of the control group.The cardiac function indexes[left ventricular end-diastolic diameter(LVEDD),left ventricular ejection fraction(LVEF),stroke volume(SV),cardiac index(CI)],self-care ability,treatment cost,hospitalization time,rehospitalization rate,mortality rate and incidence of adverse reactions were compared between the two groups.Results After supervision,LVEF,SV and CI in the observation group were higher than those in the control group,and LVEDD was lower than that in the control group(P<0.05).The scores of self-care ability,medication compliance and cognition of disease-related knowledge in the observation group were higher than those in the control group(P<0.05).The treatment cost and hospitalization time of the observation group were lower than those of the control group(P<0.05).After 3 months of follow-up,the rehospitalization rate and mortality rate of the observation group were lower than those of the control group(P<0.05).The incidence of adverse reactions in the observation group was 4.76%,which was lower than 13.33%in the control group(P<0.05).Conclusion The clinical observation and pharmaceutical care of patients with chronic heart failure based on the platform of clinical pharmacists and medical alliance are effective.It can improve the cardiac function index of patients,reduce the incidence of adverse reactions,improve self-care ability,prevent rehospitalization,reduce mortality and improve the prognosis of patients.
Clinical pharmacistMedical alliance platformChronic heart failurePharmaceutical care